We will investigate combined injury by moderate dose radiation in two models in a two- phase study. In the first phase, we will use anonymized surgical samples irradiated and wounded ex vivo by burning to study gene and protein expression differences, develop a non-invasive assay to predict successful wound healing, and test a beta adrenergic receptor antagonist as potential therapy to improve wound healing. In the second phase, we will investigate similar issues in a mouse model. Thus, the total study will combine human data (which is, however, not in vivo) and data from intact animals (which is in vivo) to obtain relevant information that can inform the development of a better mechanistic understanding of the mechanisms of wound healing in the presence of radiation damage, and to develop potential therapies that can later be tested in the clinic.

Public Health Relevance

In a nuclear warfare or terrorist incident, combined injury by radiation and burn wounding is likely. We will provide a better mechanistic understanding of the molecular biology behind healing of combined injury wounds, and will test a non-invasive assay for wound healing success and a potential therapy to improve healing. All of this would be of considerable public health benefit in such a scenario.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Exploratory/Developmental Grants Phase II (R33)
Project #
Application #
Study Section
Special Emphasis Panel (NSS)
Program Officer
Dicarlo-Cohen, Andrea L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Davis
Public Health & Prev Medicine
Schools of Medicine
United States
Zip Code
Albrecht, Huguette; Yang, Hsin-Ya; Kiuru, Maija et al. (2018) The Beta 2 Adrenergic Receptor Antagonist Timolol Improves Healing of Combined Burn and Radiation Wounds. Radiat Res 189:441-445
Mamalis, A D; Lev-Tov, H; Nguyen, D-H et al. (2014) Laser and light-based treatment of Keloids--a review. J Eur Acad Dermatol Venereol 28:689-99
Babalola, Olubukola; Mamalis, Andrew; Lev-Tov, Hadar et al. (2014) NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents. Arch Dermatol Res 306:313-330
Mamalis, Andrew; Garcha, Manveer; Jagdeo, Jared (2014) Targeting the PD-1 pathway: a promising future for the treatment of melanoma. Arch Dermatol Res 306:511-9
Dasu, Mohan R; Ramirez, Sandra R; La, Thi Dinh et al. (2014) Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing. Stem Cells Transl Med 3:745-59
Mamalis, A; Fiadorchanka, N; Adams, L et al. (2014) An immunohistochemical panel to assess ultraviolet radiation-associated oxidative skin injury. J Drugs Dermatol 13:574-578
Yang, Hsin-ya; La, Thi Dinh; Isseroff, R Rivkah (2014) Utilizing custom-designed galvanotaxis chambers to study directional migration of prostate cells. J Vis Exp :
Sivamani, Raja K; Shi, Biao; Griffiths, Elizabeth et al. (2014) Acute wounding alters the beta2-adrenergic signaling and catecholamine synthetic pathways in keratinocytes. J Invest Dermatol 134:2258-2266
Kim, Min-Ho; Gorouhi, Farzam; Ramirez, Sandra et al. (2014) Catecholamine stress alters neutrophil trafficking and impairs wound healing by ?2-adrenergic receptor-mediated upregulation of IL-6. J Invest Dermatol 134:809-817
Babalola, Olubukola; Mamalis, Andrew; Lev-Tov, Hadar et al. (2014) Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis. Arch Dermatol Res 306:1-9

Showing the most recent 10 out of 16 publications